Genotoxicity of permanent hair dye associated with melasma.
2022
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
Laboratório de Análises Clínicas do Centro Universitário FMABC, Santo André, SP, Brazil.
UI
MeSH Term
Description
Entries
D008548
Melanosis
Disorders of increased melanin pigmentation that develop without preceding inflammatory disease.
Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS.
DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006202
Hair Dyes
Dyes used as cosmetics to change hair color either permanently or temporarily.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
Related Publications
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
April 2020,
Indian journal of clinical biochemistry : IJCB,
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
February 2023,
Regulatory toxicology and pharmacology : RTP,
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
February 2002,
International journal of dermatology,
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves
July 2022,
ACS biomaterials science & engineering,
Sonia Isabel Friedlaender Reple, and
Daphine Tironi Giglio de Oliveira, and
Matheus Moreira Perez, and
Gláucia Luciano da Veiga, and
Marisa Gonzaga da Cunha, and
Fernando Luiz Affonso Fonseca, and
Beatriz da Costa Aguiar Alves